Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance

Skeletal muscle insulin resistance: role of mitochondria and other ROS sources

(2017) Sergio Di Meo et al.   JOURNAL OF ENDOCRINOLOGY

Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

(2015) Martin Fassnacht et al.   LANCET ONCOLOGY

Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors

(2014) R. L. Jones et al.   CLINICAL CANCER RESEARCH

A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors

(2014) I. Puzanov et al.   CLINICAL CANCER RESEARCH

Patients With Apparently Nonfunctioning Adrenal Incidentalomas May Be at Increased Cardiovascular Risk Due to Excessive Cortisol Secretion

(2014) Ioannis I. Androulakis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma

(2014) Marine Guillaud-Bataille et al.   PLoS One

Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency

(2013) Filippo Ceccato et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence?

(2013) Cristina L. Ronchi et al.   PLoS One

Adequately Adapted Insulin Secretion and Decreased Hepatic Insulin Extraction Cause Elevated Insulin Concentrations in Insulin Resistant Non-Diabetic Adrenal Incidentaloma Patients

(2013) Christian-Heinz Anderwald et al.   PLoS One

Progression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and β-Catenin

(2012) Joanne H. Heaton et al.   AMERICAN JOURNAL OF PATHOLOGY

Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome

(2012) Maurizio Iacobone et al.   SURGERY

Insulin-like growth factor system on adrenocortical tumorigenesis

(2011) Tamaya Castro Ribeiro et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Regulation of Insulin-like Growth Factor–Mammalian Target of Rapamycin Signaling by MicroRNA in Childhood Adrenocortical Tumors

(2010) Mabrouka Doghman et al.   CANCER RESEARCH

The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?

(2010) Giovanna Muscogiuri et al.   CLINICAL ENDOCRINOLOGY

Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling

(2009) T. J. Giordano et al.   CLINICAL CANCER RESEARCH

Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model

(2009) Michaela Luconi et al.   ENDOCRINE-RELATED CANCER

High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation

(2008) Roberto Rosati et al.   CANCER GENETICS AND CYTOGENETICS

Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma

(2008) Ferdous M. Barlaskar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adrenal incidentaloma: evaluation and management

(2008) P K Singh et al.   JOURNAL OF CLINICAL PATHOLOGY

Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies

(2008) Paola Pisani   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY